| Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view N Chadha, O Silakari European Journal of Medicinal Chemistry 134, 159-184, 2017 | 544 | 2017 |
| Oxindole: A chemical prism carrying plethora of therapeutic benefits M Kaur, M Singh, N Chadha, O Silakari European Journal of Medicinal Chemistry 123, 858-894, 2016 | 271 | 2016 |
| Thiazolidine-2, 4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions N Chadha, MS Bahia, M Kaur, O Silakari Bioorganic & Medicinal Chemistry 23 (13), 2953-2974, 2015 | 115 | 2015 |
| Hybrids: a new paradigm to treat Alzheimer’s disease M Singh, M Kaur, N Chadha, O Silakari Molecular diversity 20, 271-297, 2016 | 96 | 2016 |
| Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore-and docking-based virtual screening approach H Jasuja, N Chadha, M Kaur, O Silakari Molecular diversity 18, 253-267, 2014 | 35 | 2014 |
| Indoles: as multitarget directed ligands in medicinal chemistry N Chadha, O Silakari Key heterocycle cores for designing multitargeting molecules, 285-321, 2018 | 23 | 2018 |
| Identification of non-resistant ROS-1 inhibitors using structure based pharmacophore analysis D Pathak, N Chadha, O Silakari Journal of Molecular Graphics and Modelling 70, 85-93, 2016 | 20 | 2016 |
| Active site fingerprinting and pharmacophore screening strategies for the identification of dual inhibitors of protein kinase C and poly (ADP-ribose … N Chadha, O Silakari Molecular diversity 20, 747-761, 2016 | 15 | 2016 |
| Identification of low micromolar dual inhibitors for aldose reductase (ALR2) and poly (ADP-ribose) polymerase (PARP-1) using structure based design approach N Chadha, O Silakari Bioorganic & Medicinal Chemistry Letters 27 (11), 2324-2330, 2017 | 14 | 2017 |
| Investigating the conformational landscape of AlphaFold2-predicted protein kinase structures RR Carmen Al-Masri, Francesco Trozzi, Shu-Hang Lin, Oanh Tran, Navriti Sahni ... Bioinformatics Advances, vbad129, 2023 | 8 | 2023 |
| Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors N Chadha, AS Jaggi, O Silakari Molecular Diversity 21, 655-660, 2017 | 8 | 2017 |
| Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC D Pathak, S Choudhary, PK Singh, M Singh, N Chadha, O Silakari Molecular Diversity 25, 1091-1102, 2021 | 7 | 2021 |
| Thiazolidine-2, 4-Dione: A Potential Weapon for Targeting Multiple Pathological Conditions N Chadha, O Silakari Key Heterocycle Cores for Designing Multitargeting Molecules, 175-209, 2018 | 7 | 2018 |
| Pharmacophore and docking-based virtual screening approach for the design of new dual inhibitors of Janus kinase 1 and Janus kinase 2 H Jasuja, N Chadha, M Kaur, O Silakari SAR and QSAR in Environmental Research 25 (8), 617-636, 2014 | 7 | 2014 |
| Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3): Pharmacophore based hierarchical virtual screening H Jasuja, N Chadha, PK Singh, M Kaur, MS Bahia, O Silakari Computational Biology and Chemistry 76, 109-117, 2018 | 6 | 2018 |
| Pharmacophore based design of some multi-targeted compounds targeted against pathways of diabetic complications N Chadha, O Silakari Journal of Molecular Graphics and Modelling 76, 412-418, 2017 | 6 | 2017 |
| Computational design of new protein kinase D 1 (PKD1) inhibitors: homology-based active site prediction, energy-optimized pharmacophore, docking and database screening Nalini, N Chadha, MS Bahia, M Kaur, R Bahadur, O Silakari Molecular Diversity 22, 47-56, 2018 | 3 | 2018 |
| Imidazo[1,2-a]pyrazine inhibitors of phosphoinositide 3-kinase alpha (PI3Kα): 3D-QSAR analysis utilizing the Hybrid Monte Carlo algorithm to refine receptor-ligand … N Chadha, H Jasuja, M Kaur, M Singh Bahia, O Silakari SAR and QSAR in Environmental Research 25 (3), 221-247, 2014 | 3 | 2014 |
